Evolocumab Reduces CV Risk in Diabetic Patients Without ASCVD: VESALIUS-CV Trial
Key Points Lowering low-density lipoprotein cholesterol (LDL-C) is a cornerstone of cardiovascular…
KARDINAL Trial: Tonlamarsen Reduces Angiotensinogen Levels but Does Not demonstrate additive SBP Benefit in Single Versus Five Doses
Key Points Hypertension (HTN) remains a leading modifiable cardiovascular risk factor, with many patients exhibiting persistent elevations…
Home-Delivered DASH Diet Groceries Improve BP and LDL-C in African American Patients with Hypertension: The GoFreshRx Trial
Key Points Hypertension (HTN) disproportionately affects African- American adults in the United…
Ultrasound-Facilitated Catheter-Directed Fibrinolysis Reduces Early Clinical Deterioration in Intermediate-Risk Pulmonary Embolism: HI-PEITHO Trial
Key Points Acute pulmonary embolism (PE) remains a leading cause of cardiovascular…
Invasive Coronary Function Testing Identifies High Prevalence of Vasomotor Disorders and Drives Diagnostic Reclassification
Key Points Invasive coronary function testing: Ischemia with nonobstructive coronary arteries (INOCA)…